|
|
Line 4: |
Line 4: |
| <span style="font-size:85%"> '''Abbreviations:''' '''ACS:''' Acute coronary syndrome; '''AAA:''' Abdominal aortic aneurysm; '''RUQ:''' Right upper quadrant; '''RLQ:''' Right lower quadrant; '''LUQ:''' Left upper quadrant; '''LLQ:''' Left lower quadrant</span> | | <span style="font-size:85%"> '''Abbreviations:''' '''ACS:''' Acute coronary syndrome; '''AAA:''' Abdominal aortic aneurysm; '''RUQ:''' Right upper quadrant; '''RLQ:''' Right lower quadrant; '''LUQ:''' Left upper quadrant; '''LLQ:''' Left lower quadrant</span> |
| {{familytree/start |summary=Acute abdominal pain}} | | {{familytree/start |summary=Acute abdominal pain}} |
| {{familytree | | | | | | | | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Abdominal mass''' | | {{familytree | | | | | | | | | | | | | | Z01 | | | | | | | |Z01=Patient presents with abdominal mass}} |
| <br> | | {{familytree | | | | | | | | | | | | | |,|^|.| | | | | | |}} |
| '''Associated [[pain]]:'''<br> | | {{familytree | | | | | | | | |,|-|-| Y01 | |Y02 | | | | | | |Y01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''No associated pain''' <br>[[Hemangiomas]], [[hepatic cyst]], [[pancreatic cyst]]s (also majority of cystic neoplasms), [[Intraductal papillary mucinous neoplasm|IPMN]], pancreatic ductal [[adenocarcinoma]] (PDA), some [[neuroendocrine tumor]]s, [[retroperitoneum|retroperitoneal]] [[sarcoma]], [[lymphoma]]s, [[testicular cancer]], [[colon cancer]] [[hernia]]s|Y02='''Associated pain'''}} |
| :❑ Site (eg, a particular quadrant or diffuse, a change in location may reflect progression of the [[disease]] | | {{familytree | | | | | | | | X01 | | | |`|v|'| | | | | | |X01=<div style="float: left; text-align: left; width: 20em; padding:1em;">Reducible mass<br>❑ Suspect [[hernia]]<br>❑ Thorough history, past surgical history, and physical exam (lying down and standing)}} |
| | {{familytree | | | | | | | | |!| | | | | |!| | | | | | | |}} |
| | {{familytree | | | | | | | | W01 | | | | |!| | | | | | | |W01=<div style="float: left; text-align: left; width: 20em; padding:1em;">Abdominal [[US]]<br>Elective repair}} |
| | {{familytree | | | | | | | | | | | | | | A01 | | | | | | | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Characterise the pain'''<br> |
| | :❑ Site (eg, a particular quadrant or diffuse |
| :❑ Onset (eg, sudden, gradual) | | :❑ Onset (eg, sudden, gradual) |
| :❑ Quality (eg, dull, sharp, colicky, waxing and waning) | | :❑ Quality (eg, dull, sharp, colicky, waxing and waning) |
Line 68: |
Line 72: |
| :❑ Detection of masses on palpating the abdomen | | :❑ Detection of masses on palpating the abdomen |
| :❑ [[Carnett's sign]] | | :❑ [[Carnett's sign]] |
| ❑ [[Pelvic exam]] in females<br> | | ❑ [[Pelvic exam]] in females / [[testicular examination]] in males<br> |
| ❑ [[Testicular examination]] in males<br>
| | ❑ [[Cardiovascular system]]<br> |
| ❑ Cardiovascular system<br> | | ❑ [[Respiratory system]]<br> |
| ❑ Respiratory system<br> | | ❑ Anorectal [[bleeding]] (maybe due to [[colorectal cancer|CRC]] or [[IBD]])<br> |
| ❑ Anorectal (bleeding)<br> | |
| ❑ [[Signs of sepsis]]: [[tachycardia]], decreased urination, and [[hyperglycemia]], [[confusion]], [[metabolic acidosis]] with compensatory [[respiratory alkalosis]], [[hypotension]], decreased [[systemic vascular resistance]], and [[coagulation]] dysfunctions<br> | | ❑ [[Signs of sepsis]]: [[tachycardia]], decreased urination, and [[hyperglycemia]], [[confusion]], [[metabolic acidosis]] with compensatory [[respiratory alkalosis]], [[hypotension]], decreased [[systemic vascular resistance]], and [[coagulation]] dysfunctions<br> |
| | '''Signs of [[peritonitis]] or [[shock]]'''<br> ❑ [[fever]], abdominal [[tenderness]], [[guarding]], [[rebound tenderness]], [[rigidity]], [[confusion]], [[hypotension]] , and low [[urine output]] |
| </div>}} | | </div>}} |
| | {{familytree | | | | | | | | | | |,|-|-|-|^|-|-|.| | | | }} |
| | {{familytree | | | | | | | | | | W01 | | | | | W02 | | | | | | |W01=<div style="float: left; text-align: left; line-height: 150% ">'''Patient is unstable,''' <br> '''Stabilize the patient:'''<br> ❑ Establish two large-bore intravenous peripheral lines<br> ❑ [[NPO]] until the patient is stable<br> ❑ Supportive care (fluids and electrolyes as required)<br> ❑ Place nasogastric tube if there is bleeding, obstruction, significant [[nausea]] or [[vomiting]]<br> ❑ Place [[foley catheter]] to monitor volume status<br> ❑ Cardiac monitoring<br> ❑ Supplemental oxygen as needed<br> ❑ Administer early [[antibiotics]] if indicated </div>|W02='''Patient is stable'''}} |
| | {{familytree | | | | | | | | | | |`|-|-|-|v|-|'| | | | | }} |
| {{familytree | | | | | | | | | | | | | | |!| | | | | | | }} | | {{familytree | | | | | | | | | | | | | | |!| | | | | | | }} |
| {{familytree | | | | | | | | | | | | | | C01 | | | | | | | |C01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Consider extraabdominal differential diagnosis:'''<BR> ❑ aaaa</div>}}
| |
| {{familytree | | | | | | | | | | | | | | |!| | | | | | | }} | | {{familytree | | | | | | | | | | | | | | |!| | | | | | | }} |
| {{familytree | | | | | | | | | | | | | | E01 | | | | | | | | | |E01=❑ Assess hemodynamic stability }} | | {{familytree | | | | | | | | | | | | | | E01 | | | | | | | | | |E01=<div style="float: left; text-align: left; line-height: 150% ">'''Order laboratory tests:'''<br> ❑ [[Pregnancy test]] (required in women of child-bearing age) <br> |
| | ❑ [[CBC]], [[Hematocrit]] ([[thrombocytopenia]], [[leukopenia]], [[anemia]] may be associated with [[splenomegaly]])<br> |
| | ❑ [[Urinalysis]]<br> ❑[[ESR]]<br>❑ [[ABG]]<br> ❑ [[D dimer]]<br>❑ [[Serum lactate]]<br> ❑ [[BMP]] ([[urea]], [[creatinine]], [[serum electrolytes]], [[BSL]]) <br> ❑ [[Amylase]] <br> ❑ [[Lipase]] <br> ❑ [[Triglyceride]] <br>❑[[Liver function tests]] (total [[bilirubin]], direct [[bilirubin]], [[albumin]], [[AST]], [[ALT]], [[Alkaline phosphatase]], [[GGT]]) }} |
| {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | |}} | | {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | |}} |
| {{familytree | | | | | | | | | | | | | | Z02 | | | | | | | | |Z02=<div style="float: left; text-align: left; line-height: 150% ">'''If the patient is unstable,''' <br> '''Stabilize the patient:'''<br> ❑ Establish two large-bore intravenous peripheral lines<br> ❑ [[NPO]] until the patient is stable<br> ❑ Supportive care (fluids and electrolyes as required)<br> ❑ Place nasogastric tube if there is bleeding, obstruction, significant [[nausea]] or [[vomiting]]<br> ❑ Place [[foley catheter]] to monitor volume status<br> ❑ Cardiac monitoring<br> ❑ Supplemental oxygen as needed<br> ❑ Administer early antibiotics if indicated </div>}} | | {{familytree | | | | | | | | | | | | | | Z02 | | | | | | | | |Z02=}} |
| {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | |}} | | {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | |}} |
| {{familytree | | | | | | | | | | | | | | Z01 | | | | | | | | | | |Z01 =<div style="float: left; text-align: left; line-height: 150% ">'''If the patient is stable,'''<br> '''Order laboratory tests:'''<br> ❑ [[Pregnancy test]] (required in women of child-bearing age) <br> | | {{familytree | | | | | | | | | | | | | | Z01 | | | | | | | | | | |Z01 ='''Order imaging studies:''' <br> ❑ Order urgent trans abdominal [[ultrasound]] (TAUSG)<br> ❑ [[Abdominal CT]]<br> ❑ [[ECG]]<br> ❑ [[MRCP]] <br> ❑ [[Abdominal x-ray]] <br> ❑ [[Angiography]]<br> ❑ Diagnostic [[paracentesis]]<br> |
| ❑ [[CBC]], [[Hematocrit]] ([[thrombocytopenia]], [[leukopenia]], [[anemia]] may be associated with [[splenomegaly]])<br>
| |
| ❑ [[Urinalysis]]<br> ❑[[ESR]]<br>❑ [[ABG]]<br> ❑ [[D dimer]]<br>❑ [[Serum lactate]]<br> ❑ [[BMP]] ([[urea]], [[creatinine]], [[serum electrolytes]], [[BSL]]) <br> ❑ [[Amylase]] <br> ❑ [[Lipase]] <br> ❑ [[Triglyceride]] <br>❑[[Liver function tests]] (total [[bilirubin]], direct [[bilirubin]], [[albumin]], [[AST]], [[ALT]], [[Alkaline phosphatase]], [[GGT]])
| |
| ----
| |
| '''Order imaging studies:''' <br> ❑ Order urgent trans abdominal [[ultrasound]] (TAUSG)<br> ❑ [[Abdominal CT]]<br> ❑ [[ECG]]<br> ❑ [[MRCP]] <br> ❑ [[Abdominal x-ray]] <br> ❑ [[Angiography]]<br> ❑ Diagnostic [[paracentesis]]<br> | |
| ---- | | ---- |
| '''''*Order the tests to rule in a suspected diagnosis<br> or to assess a case of unclear etiology'''''<br> '''''*In case of elderly patients, immunocompromised<br> or those unable to provide a comprehensive<br> history, order broader range of tests''''' </div>}} | | '''''*Order the tests to rule in a suspected diagnosis<br> or to assess a case of unclear etiology'''''<br> '''''*In case of elderly patients, immunocompromised<br> or those unable to provide a comprehensive<br> history, order broader range of tests''''' </div>}} |
| {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}} | | {{familytree | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}} |
| {{familytree | | | | | | | | | | | | | | A01 | | | | | |A01=<div style="float: left; text-align: left; line-height: 150% "> '''Signs of [[peritonitis]] or [[shock]]'''<br> ❑ [[Fever]]<br> ❑ Abdominal tenderness<br> ❑ Abdominal gaurding<br> ❑ Rebound tenderness ([[blumberg sign]])<br> ❑ Diffuse abdominal rigidity<br> ❑ [[Confusion]]<br> ❑ Weakness<br> ❑ Low blood pressure <br> ❑ Decreased urine output<br> ❑ Tachycardia<br> </div>}} | | {{familytree | | | | | | | | | | | | | | A01 | | | | | |A01=}} |
| {{familytree | | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} | | {{familytree | | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }} |
| {{familytree | | | | | | | C01 |-|-|-|-|-|.| | | | | | C03 | | | | | | | |C01=No|C02=No|C03=Yes}} | | {{familytree | | | | | | | C01 |-|-|-|-|-|.| | | | | | C03 | | | | | | | |C01=No|C02=No|C03=Yes}} |
Line 96: |
Line 100: |
| {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} |
| {{familytree/end}} | | {{familytree/end}} |
|
| |
| Table illustrates common imaging findings and management of stabke abdominal masses.<ref name="pmid10524843">{{cite journal |vauthors=Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y |title=Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI |journal=J Comput Assist Tomogr |volume=23 |issue=5 |pages=670–7 |date=1999 |pmid=10524843 |doi=10.1097/00004728-199909000-00004 |url=}}</ref><ref name="pmid22895392">{{cite journal |vauthors=Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Wasan H |title=Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update |journal=Gut |volume=61 |issue=12 |pages=1657–69 |date=December 2012 |pmid=22895392 |doi=10.1136/gutjnl-2011-301748 |url=}}</ref><ref name="pmid28229074">{{cite journal |vauthors=Olthof SC, Othman A, Clasen S, Schraml C, Nikolaou K, Bongers M |title=Imaging of Cholangiocarcinoma |journal=Visc Med |volume=32 |issue=6 |pages=402–410 |date=December 2016 |pmid=28229074 |pmc=5290452 |doi=10.1159/000453009 |url=}}</ref><ref name="pmid25960793">{{cite journal |vauthors=Pawlak M, Bury K, Śmietański M |title=The management of abdominal wall hernias - in search of consensus |journal=Wideochir Inne Tech Maloinwazyjne |volume=10 |issue=1 |pages=49–56 |date=April 2015 |pmid=25960793 |pmc=4414108 |doi=10.5114/wiitm.2015.49512 |url=}}</ref><ref name="pmid25383252">{{cite journal |vauthors=Becker LC, Kohlrieser DA |title=Conservative management of sports hernia in a professional golfer: a case report |journal=Int J Sports Phys Ther |volume=9 |issue=6 |pages=851–60 |date=November 2014 |pmid=25383252 |pmc=4223293 |doi= |url=}}</ref><ref name="pmid26739977">{{cite journal |vauthors=Zhang HY, Liu D, Tang H, Sun SJ, Ai SM, Yang WQ, Jiang DP, Zhang LY |title=The effect of different types of abdominal binders on intra-abdominal pressure |journal=Saudi Med J |volume=37 |issue=1 |pages=66–72 |date=January 2016 |pmid=26739977 |pmc=4724682 |doi=10.15537/smj.2016.1.12865 |url=}}</ref>
| |
| {| style="border: 2px solid #4479BA; align="left"
| |
| ! style="width: 100px; background: #4479BA;" | {{fontcolor|#FFF|Cause of abdominal mass}}
| |
| ! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|'''CT scan'''}}
| |
| ! style="width: 70px; background: #4479BA;" | {{fontcolor|#FFF|'''Ultrasound'''}}
| |
| ! style="width: 100px; background: #4479BA;" | {{fontcolor|#FFF|'''MRI'''}}
| |
| ! style="width: 70px; background: #4479BA;" | {{fontcolor|#FFF|'''PET scan'''}}
| |
| ! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|'''Management'''}}
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Hepatic cyst]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Reserved for more complicated cases.
| |
| For more information [[Hepatic cysts|click here]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Most useful initial test.
| |
| *Assess cyst size, type, location within the liver, type, and anatomic relations with surroundings.
| |
| *Follow-up with [[US]] only if cyst id >4 cm.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Rule out [[infection]] and [[malignancy]] before diagnosis.
| |
| *[[Fever]] + [[cyst]]= suspect [[pyogenic liver abscess]]/ other infection.
| |
| *Asymptomatic simple cyst: no treatment required.
| |
| *Symptomatic cyst: [[sclerotherapy]]/ wide unroofing surgery.
| |
| *[[Echinococcosis]]: [[anthelmintic]]s/ and surgery), [[amebic liver abscess]]: [[metronidazole]], [[pyogenic liver abscess]]: [[Pyogenic liver abscess medical therapy|antibiotic]] + percutaneous drainage.
| |
| *[[Cystadenoma]] and cystadenocarcinoma: surgically removed/ lobectomy/partial hepatectomy.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Hemangioma]]s
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Asymmetric peripheral enhancement on IV contrast (diagnostic potential)
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;"|
| |
| *Biopsy is NOT recommended due to bleeding risk
| |
| *Majority of [[patients]] do not require intervention.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Hepatic adenoma]]s
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Well-circumscribed hypo-intense lesions.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Malignant potential and bleeding risk.
| |
| *[[Discontinue|D/C]] [[OCP]] may lead to involution.
| |
| *>4 cm [[hepatic adenoma|adenoma]] requires surgical resection.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Hepatocellular carcinoma]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | With IV contrast, diffuse enhancement with arterial phase contrast, and then washout during delayed venous images.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Resection (small single lesions, no/limited cirrhosis)/ liver transplant (advanced [[cirrhosis]]) but no extrahepatic disease.
| |
| *If a [[patient]] with [[liver cirrhosis|cirrhosis]] presents with a >1cm liver mass, pursue a definitive diagnosis to rule out HCC.
| |
| *Non-surgical transarterial chemoembolization (TACE) and radiofrequency ablation (RFA).
| |
| *[[Sorafenib]] ([[tyrosine kinase inhibitor]]) if patient is not a candidate for resection/ transplant.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Focal nodular hyperplasia]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Well-circumscribed mass with central stellate scar. Hyperintense on arterial phase and isodense on venous phase (IV contrast).
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Reassure and observe (no malignant potential)
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Cholangiocarcinoma]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Lesion occurs in the periphery of [[liver]]
| |
| *Primary staging: Higher [[sensitivity|Sn]] in detecting extrahepatic invasion and vascular involvement.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Modality of choice for [[diagnosis]] and [[staging]]
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Surgical resection with negative margin.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Hepatic metastatsis
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Hypo-intense on venous phase contrast.Does not reliably detect lesions <1 cm.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *More [[sensitivity|Sn]] than CT and can detect lesions < 1 cm.
| |
| *T1 weighted hypointense and T2 weighted hyper-intense images.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Surgical resection of hepatic metastases after appropriate selection based on survival benefit.
| |
| *Radiofrequency ablation if hepatic resection is not possible.
| |
| *A multidisciplinary approach is required.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Splenomegaly]]
| |
|
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Important in pre-operative planning for [[splenectomy]] via an open versus laparoscopic approach.
| |
| *CT volumetry measures the true size of an enlarged spleen, detects accessory splenic tissue.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Doppler can determine the splenic artery and splenic vein patency.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Splenectomy relieves symptoms and induces hyposplenism.
| |
| *[[Overwhelming post-splenectomy infection|OPSI]] is a life-threatening complication.
| |
| *[[Overwhelming post-splenectomy infection|click here]] to read more.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Cystic [[pancreas|pancreatic]] mass
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Serous cystic tumor: Hypervascular lesions with central scar, septations, and central/ sunburst calcification. Microcystic ''Honeycomb'' appearance.
| |
| *Intraductal papillary mucinous neoplasm (IPMN): Communicates with main- pancreatic duct, branch duct or both.
| |
| *Mucinous cystic neoplasm (MCN): Well encapsulated, circular, unilocular or septated cysts with wall calcifications.
| |
| *Solid pseudopapillary neoplasm (SPN): Large solid and cystic components, [[hemorrhage]], [[necrosis]] and/without [[calcifications]].
| |
| *A solid component in IPMN and MCN may suggest malignancy.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Esophageal [[US]]-guided [[Needle aspiration biopsy|FNA]] with cyst fluid analysis or [[ERCP]] for diagnosis.
| |
| *Non-neoplastic cysts and serous cystic tumor are removed only if symptomatic.
| |
| *IPMN communicating with the main duct/ symptomatic/ with malignancy suspician is resected. Other cases are monitored.
| |
| *MCN and SPN have a significant malignant potential and should be removed.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Solid [[pancreas|pancreatic]] mass
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Helps in diagnosis, staging, treatment planning and followup.
| |
| *Pancreatic Ductal Adenocarcinoma (PDA): CT with IV contrast is the initial test of choice. A hypodense lesion that disrupting normal architecture of the [[pancreas]] accompanied by pancreatic / [[common bile duct|CBD]] dilatation may be demonstrated. A “double-duct” sign may also be demonstrated.
| |
| *Acinar Cell Carcinoma (ACC): Solid or cystic mass is demonstrated.
| |
| *Pancreatic Neuroendocrine Tumors (PNET): CT must be obtained among all patients nonetheless. On IV contrast, hypervascular lesions on the arterial phase are demonstrated.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *PDA:Endoscopic ultrasound (EUS)/ [[endoscopic retrograde cholangiopancreatography|ERCP]] with tissue sampling are diagnostic tools.
| |
| *PNET: EUS > CT at locating the lesion and biopsy at the same time.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |MRI can be utilised instead of CT.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *PDA: Resectable pancreatic head PDA us treated with pancreaticoduodenectomy ([[Whipple procedure]]). For the body and tail distal pancreatectomy is performed. [[Chemotherapy]] and [[radiotherapy]] are administered and/or post surgery.
| |
| *ACC: Surgical resection.
| |
| *PNET: Serum hormone testing is the mainstay of management. Surgical resection is the primary method of treatment as majority of tumors have malignant potential. Additional medical therapy may be required.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Retroperitoneal Sarcoma
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Chest, abdomen and pelvis contrast-enhanced CT for diagnosis, staging, and ruling out metastatic disease.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |MRI with gadolinium is an alternative in case of contrast allergy, pelvic involvement, and equivocal CT imaging findings.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Not routinely used.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Image-guided percutaneous core needle biopsy is considered safe and helps guide treatment modalities and the extent of surgery.
| |
| *R0 surgical resection is a potentially curative treatment method.
| |
| |-
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Hernia]]s
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |First line imaging technique. Demonstration of bowel contents confims the disease.
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| | style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
| |
| *Conservative approach/ elastic binders.
| |
| *Emergency surgery: abdominal contents compression/ strangulation.
| |
| *Elective surgery: Symptomatic hernia/ patient preference.
| |
| |-
| |
| |}
| |
|
| |
|
| |
| AFP level above 500 mg/dL should raise concern for the presence of HCC.
| |